We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Must Bolster Efforts to Prevent Conflicts of Interest, OIG Says
FDA Must Bolster Efforts to Prevent Conflicts of Interest, OIG Says
February 17, 2006
The FDA is not doing enough to ensure its employees’ outside activities comply with federal conflict-of-interest requirements, according to an HHS Office of Inspector General (OIG) report.